Anxiolytic agents with reduced sedative and ataxic effects
Details for Australian Patent Application No. 2003230754 (hide)
International Classifications
Event Publications
14 August 2003 Complete Application Filed
Priority application(s): 60/368,408 28.03.02 US
20 November 2003 Application Open to Public Inspection
Published as AU-B-2003230754
10 March 2005 Amendment Made
The nature of the amendment is: Delete the co-inventors Lelas, Snjezana and McElroy John F.
25 October 2007 Application Accepted
Published as AU-B-2003230754
29 November 2007 Application for Amendment
The nature of the amendment is: Amend co-inventor name from Li, Xioayan to Li, Xiaoyan. Address for service in Australia - Shelston IP Level 21 60 Margaret Street Sydney NSW 2000 Amendments, Section 104
6 March 2008 Amendment Made
The nature of the amendment is: Amend the name of the co-inventor from Li, Xioayan to Li, Xiaoyan 2003249604 CV Therapeutics, Inc. The nature of the amendment is: Amend the invention title to read A2B adenosine receptor antagonists
13 March 2008 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser